Regulatory affairs takes off at Quanta
Ongoing business growth and development has seen Quanta go from strength to strength in recent years, which has led us to expand into new subsectors and markets. As part of this, we’re developing our focus within regulatory affairs, an increasingly important part of the life sciences sector.
Regulatory affairs is a relatively new market, and one that’s set to boom in the coming years as governments become even more concerned with controlling the safety and efficacy of pharmaceuticals, medical devices and other products within life sciences. Its rapid growth is due to ever-evolving product safety requirements, new technologies, changing customer requirements and relentless regulatory updates. People who work within this space are tasked with not only keeping up to date with, understanding and complying with the latest regulations, but also creating opportunities within the highly-regulated life sciences landscape. Because of this, skilled and qualified regulatory affairs professionals are in hot demand by organisations across the UK, Europe and beyond.
At Quanta, we’ve established a regulatory affairs division to support the growing demand from both clients and candidates in the industry. After being approached by individuals and businesses regarding our regulatory affairs capacity, we realised the demand for this type of consultancy was only going to increase. Led by Andrew Pieri, the team is building relationships with new and existing clients and sourcing the best candidates on the market.
An average day for the team consists of speaking with clients – typically regulatory affairs managers and directors – about their team, products and recruitment needs. This is balanced with candidate sourcing and attraction, with the team focused on expanding our existing candidate base to cater to the niche locations and requirements that our clients have. We recruit for both contract and permanent professionals, with our new permanent division helping to source the right candidates for this area. Candidate attraction is always a priority for us, with the team using our internal database as well as other tools to identify talent.
New business is also important for us as we continue to grow within regulatory affairs. This dedicated vertical sales consultancy means we focus all our attention on both clients and candidates, which allows us to really immerse ourselves in the world of regulatory affairs and stay on the cutting edge of movements and trends, both for candidates and clients. As the scope of the market changes and our clients demand more qualified professionals, we expect to see significant growth within Quanta’s regulatory affairs function, so the team is constantly working to keep their knowledge of the industry updated in line with market trends. Ongoing research is key – we expect our candidates to be up-to-date with the latest rules and guidelines, so we make sure we do the same ourselves.
Within the market currently, we’re seeing a lot of demand in CMC – chemistry, manufacturing and control – as well as labelling and post-approval. Within the pre-clinical and clinical stages, the main focus is on CMC regulatory affairs and the life cycle management of projects. There’s currently a strong pool of qualified professionals on the market, which means it’s up to us to identify and vet the best people for each role that comes through. With life science markets across the UK, wider Europe, Asia and North America opening up to more regulatory affairs work, we’re looking forward to seeing yet more exciting opportunities for professionals in this area.
If you’re interested in learning more about regulatory affairs at Quanta, we’d love to chat with you. Contact us to find out more, or take a look at our latest vacancies.